101001-69-8 Usage
Classification
Aromatic amine This compound is classified as an aromatic amine due to the presence of a pyrrole ring and an amino group in its structure.
Applications
Synthesis of pharmaceuticals, agrochemicals, dyes, and pigments 1H-Pyrrole-2-carbonitrile,1-(2-propenyl)-(9CI) is used as a building block or intermediate in the synthesis of various pharmaceuticals, agrochemicals, dyes, and pigments.
Physical appearance
Colorless to yellow liquid with a faint odor The compound is a liquid with a very subtle smell, and its color ranges from colorless to yellow.
Solubility
Soluble in organic solvents such as ethanol and acetone 1H-Pyrrole-2-carbonitrile,1-(2-propenyl)-(9CI) can dissolve in common organic solvents, making it suitable for use in various chemical reactions and processes.
Biological activity
Potential pharmacological properties This compound is known to have potential biological activity, and researchers are studying its possible pharmacological properties for future applications in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 101001-69-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,0,0 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 101001-69:
(8*1)+(7*0)+(6*1)+(5*0)+(4*0)+(3*1)+(2*6)+(1*9)=38
38 % 10 = 8
So 101001-69-8 is a valid CAS Registry Number.
101001-69-8Relevant articles and documents
GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
-
Page/Page column 143, (2008/12/06)
Compounds of Formula (IA) (IA), and Formula (IB) (IB), wherein R1, R2, R3, A, B, C, D, E, G, X, Y, and Z are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
